No - SLX's function would be to provide feedstock to facilities...

No - SLX's function would be to provide feedstock to facilities such as this. The ⁹⁹Mo product provided by this facility currently comes from the Lucas Heights reactor but an alternative path is to separate out (from natural Mo) to ¹⁰⁰Mo isotope which can then be put in a cyclotron and turned into the ⁹⁹Mo product - currently Lucas Height does not use this production method and it appears that SLX is biding its time to provide any ¹⁰⁰Mo feedstock.

Another medical product ¹⁷⁷Lu is currently being used to treat/diagnose metastatic prostrate cancer and as I understand it likely to be extended to treat/diagnose other types of metastatic cancer. The feedstock for this process is ¹⁷⁶Yb (which is then irradiated (at Lucas heights) to produce ¹⁷⁷Lu) is the process SLX have identified (MIST) and are evidently now working on (they got the cash in the last CR - A$28m see slide 19 of the CR presentation HERE). The A$28m covered MIST and Zero Spin Si but they now appear to be getting separate funding for the Zero Spin Si production facility. I would think it likely that SLX are now modifying the Zero Spin Si prototype to separate ¹⁷⁶Yb whilst. they are building the Zero spin Si commercial production facility (it will need different laser frequencies and feedstock).